LINICAL PROTEIN 5 CALIBRATION VERIFIERS LEVELS A-E FOR BECKMAN COULTER ARRAY AND IMMAGE PROTEIN SYSTEMS
K030150 · Cliniqa Corporation · JJY · Jan 28, 2003 · Clinical Chemistry
Device Facts
| Record ID | K030150 |
| Device Name | LINICAL PROTEIN 5 CALIBRATION VERIFIERS LEVELS A-E FOR BECKMAN COULTER ARRAY AND IMMAGE PROTEIN SYSTEMS |
| Applicant | Cliniqa Corporation |
| Product Code | JJY · Clinical Chemistry |
| Decision Date | Jan 28, 2003 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 862.1660 |
| Device Class | Class 1 |
Intended Use
LiniCAL® Protein 5 Calibration Verifiers Levels A - E for Beckman Coulter Array and Immage® Protein Systems is intended for use as an assayed quality control material for analysis.
Device Story
LiniCAL Protein 5 Calibration Verifiers are assayed quality control materials used to verify the performance and linearity of Beckman Coulter Array and Immage Protein Systems. The device consists of five levels (A-E) of liquid-stable, human serum-based materials. These are used by laboratory technicians to monitor the accuracy and precision of protein analysis assays. By comparing the measured values of the verifiers against the expected assayed values, the user can assess the calibration status and analytical performance of the instrument. This process helps ensure the reliability of patient test results, facilitating accurate clinical decision-making by healthcare providers.
Clinical Evidence
Bench testing only. No clinical data provided.
Technological Characteristics
Liquid-stable, human serum-based quality control material. Five levels (A-E). Designed for use with Beckman Coulter Array and Immage Protein Systems. Class I device, product code JJY.
Indications for Use
Indicated for use as an assayed quality control material for analysis on Beckman Coulter Array and Immage Protein Systems in a clinical laboratory setting.
Regulatory Classification
Identification
A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls.
Reference Devices
- Beckman Coulter Array® Protein System
- Beckman Coulter Immage® Protein System
Related Devices
- K023250 — LINICAL PROTEIN 2 CALIBRATION VERIFIERS LEVELS A-E FOR THE BECKMAN-COULTER IMMAGE · Cliniqa Corporation · Oct 17, 2002
- K013332 — LINICAL PROTEIN I CALIBRATION VERIFIERS LEVELS A=E FOR BECKMAN COULTER IMMAGE · Cliniqa Corporation · Nov 20, 2001
- K022867 — LINICAL PROTEIN 3 CALIBRATION VERIFIERS LEVELS A - E FOR THE BECKMAN-COULTER IMMAGE · Cliniqa Corporation · Oct 2, 2002
- K022885 — LINICAL PROTEIN 4 CALIBRATION VERIFIERS LEVELS-A-E FOR BECKMAN COULTER IMMAGE · Cliniqa Corporation · Oct 2, 2002
- K031577 — LINICAL PROTEIN 2 CALIBRATION VERIFIERS LEVELS A-E FOR BECKMAN COULTER ARRAY PROTEIN SYSTEMS · Cliniqa Corporation · Aug 6, 2003
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of an eagle with three wavy lines extending from its head, representing the department's mission to protect and promote the health and well-being of Americans.
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
JAN 28 2003
Ms. Carol Ruggiero Director of Regulatory Affairs CLINIQA Corporation 1432 South Mission Road Fallbrook, California 92028
Re: k030150
> Trade/Device Name: LiniCAL™ Protein 5 Calibration Verifiers Levels A - E for Beckman Coulter Array® and Immage® Protein Systems Regulation Number: 21 CFR § 862.1660 Regulation Name: Quality Controls Material, (Assayed and Unassayed) Regulatory Class: I Product Code: JJY Dated: January 14, 2003 Received: January 15, 2003
Dear Ms. Ruggiero:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed
{1}------------------------------------------------
Page 2 -
If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 594-3084. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours,
Steven Sutman
Steven I. Gutman, M.D., M.B.A. Director Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
510(k) Number (if known):
030/50
Device Name: LiniCAL® Protein 5 Calibration Verifiers Levels A – E for Beckman Coulter Array® and Immage® Protein Systems
Indications For Use:
LiniCAL® Protein 5 Calibration Verifiers Levels A - E for Beckman Coulter Array and Immage® Protein Systems is intended for use as an assayed quality control material for analysis.
## (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Sean Cooper
Division Sign Off
on of Clinical Laboratory Devices
510(k) Number K1030150
Prescription Use
(Per 21 CFR 801.109)
OR
Over-The-Counter Use